Scott H. Goodnight

3.3k total citations · 1 hit paper
60 papers, 2.5k citations indexed

About

Scott H. Goodnight is a scholar working on Hematology, Surgery and Nutrition and Dietetics. According to data from OpenAlex, Scott H. Goodnight has authored 60 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 19 papers in Surgery and 17 papers in Nutrition and Dietetics. Recurrent topics in Scott H. Goodnight's work include Fatty Acid Research and Health (17 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Scott H. Goodnight is often cited by papers focused on Fatty Acid Research and Health (17 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers) and Antiplatelet Therapy and Cardiovascular Diseases (10 papers). Scott H. Goodnight collaborates with scholars based in United States, Kenya and Canada. Scott H. Goodnight's co-authors include William S. Harris, D. Roger Illingworth, Connor We, Bruce M. Coull, Dennis Briley, Arne Nordøy, Samuel I. Rapaport, T W Barrowcliffe, Elizabeth M. Van Cott and Michael Laposata and has published in prestigious journals such as New England Journal of Medicine, Circulation and Blood.

In The Last Decade

Scott H. Goodnight

57 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

1982 566 citations Scott H. Goodnight, D. Roger Illingworth et al. profile →

Peers

Countries citing papers authored by Scott H. Goodnight

Since Specialization

Citations

This map shows the geographic impact of Scott H. Goodnight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott H. Goodnight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott H. Goodnight more than expected).

Fields of papers citing papers by Scott H. Goodnight

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott H. Goodnight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott H. Goodnight. The network helps show where Scott H. Goodnight may publish in the future.

Co-authorship network of co-authors of Scott H. Goodnight

This figure shows the co-authorship network connecting the top 25 collaborators of Scott H. Goodnight. A scholar is included among the top collaborators of Scott H. Goodnight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott H. Goodnight. Scott H. Goodnight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban. 1998 ·PubMed ·Michael Laposata, (unknown), Elizabeth M. Van Cott, T W Barrowcliffe, Scott H. Goodnight, (unknown)	198
2	Aspirin therapy for cardiovascular disease 1996 ·Current Opinion in Hematology ·Scott H. Goodnight	16
3	Acute promyelocytic leukaemia in the alltrans retinoic acid era 1996 ·Medical Oncology ·Thomas G. DeLoughery, Scott H. Goodnight	2
4	Prospective comparison of infrainguinal bypass grafting in patients with and without antiphospholipid antibodies 1996 ·Journal of Vascular Surgery ·Raymond W. Lee, Lloyd M. Taylor, Gregory J. Landry, Scott H. Goodnight, Gregory L. Moneta, James M. Edwards, Richard A. Yeager, John M. Porter	23
5	Thrombosis and hemorrhage 1996 ·Journal of Vascular Surgery ·Scott H. Goodnight	58
6	Molecular Detection of a Common Mutation in Coagulation Factor V Causing Thrombosis via Hereditary Resistance to Activated Protein C 1995 ·Diagnostic Molecular Pathology ·Xiao‐Yuan Liu, (unknown), Chris W.M. Grant, Virginia H. Morthland, Scott H. Goodnight, Richard D. Press	32
7	Antiphospholipid Antibodies in Vascular Surgery Patients A Cross-Sectional Study 1994 ·Annals of Surgery ·Lloyd M. Taylor, (unknown), Ronald L. Dalman, Gerard P. Sexton, Scott H. Goodnight, John M. Porter	45
8	DISSEMINATED INTRAVASCULAR COAGULATION IN CADAVERIC ORGAN DONORS INCIDENCE AND EFFECT ON RENAL TRANSPLANTATION 1993 ·Transplantation ·Thomas R. Hefty, (unknown), (unknown), Scott H. Goodnight, (unknown)	30
9	Fish oil and vascular disease 1991 ·Trends in Cardiovascular Medicine ·Scott H. Goodnight	20
10	Increased Activity of Factor VII and Factor VII-Phospholipid Complex Measured Using a Normotest System in Subjects with Hyperlipidemia 1990 ·Pathophysiology of Haemostasis and Thrombosis ·Arne Nordøy, D. Roger Illingworth, W E Connor, Scott H. Goodnight	15
11	Neurological disease associated with antiphospholipid antibodies 1989 ·Annals of Neurology ·Dennis Briley, Bruce M. Coull, Scott H. Goodnight	183
12	The Vascular Effects of omega-3 Fatty Acids. 1989 ·Journal of Investigative Dermatology ·Scott H. Goodnight	11
13	Effects of Dietary Fish Oil and Omega-3 Fatty Acids on Platelets and Blood Vessels 1988 ·Seminars in Thrombosis and Hemostasis ·Scott H. Goodnight	14
14	An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases 1987 ·Arthritis & Rheumatism ·(unknown), Scott H. Goodnight, Robert M. Bennett	95
15	Impact of factor VIII deficiency on clotting factor utilization in the United States 1983 ·La Ricerca in Clinica e in Laboratorio ·(unknown), Scott H. Goodnight, (unknown), Jan Schwarz, (unknown), Sandor S. Shapiro, (unknown)	3
16	Antiplatelet therapy for mitral stenosis? 1980 ·Circulation ·Scott H. Goodnight	12
17	Prospective randomized study evaluating the effects of antiplatelet or anticoagulant therapy on aortocoronary saphenous vein bypass graft patency 1978 ·Circulation ·George A. Pantely, Scott H. Goodnight, Henry DeMots	1
18	Effects of infusion of cardiotomy suction blood during extracorporeal circulation for coronary artery bypass surgery 1977 ·Journal of Thoracic and Cardiovascular Surgery ·J. Edward Okies, Scott H. Goodnight, (unknown), Reid S. Connell, Albert Starr	17
19	Circulating Factor IX Antigen-Inhibitor Complexes in Hemophilia B- Following Infusion of a Factor IX Concentrate 1977 ·Thrombosis and Haemostasis ·Scott H. Goodnight, Catherine W. Britell, Kirk D. Wuepper, Bjarne Østerud	2
20	Platelet Survival Using Aspirin: Studies in Patients with Artificial Cardiac Valves 1977 ·Thrombosis and Haemostasis ·Scott H. Goodnight, (unknown), (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact